Already a member? Sign in
Zolmitriptan is used to treat the symptoms of migraine headache. It is in a class of medications called selective serotonin (5-HT) receptor agonists. It does not prevent migraine headaches. It comes in oral tablet form or as a nasal spray.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Migraine | 72 | 13 |
|
|
|
|
|
| Migraine headaches | 52 | 11 |
|
|
|
||
| Migraine with aura | 5 | 0 | |||||
| Other | 5 | 3 |
|
|
|
||
| Atypical Migraine | 4 | 1 |
|
||||
| Headaches | 3 | 1 |
|
See all 90 patients currently taking Zolmitriptan
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Zolmitriptan
| Face Tingling | 3 | |
|---|---|---|
| Chest pain | 2 | |
| Drowsiness | 2 | |
| Dizziness | 1 | |
| Sneezing | 1 | |
| Numbness in right side | 1 | |
| See all 11 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Zolmitriptan. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 28 | ||
| Doctor's advice | 12 | ||
| Side effects too severe | 11 | ||
| Other | 8 | ||
| Expense | 4 | ||
| Course of treatment ended | 2 | ||
| Personal research | 1 | ||
| Change in health plan coverage | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Zolmitriptan
Always |
22 | 79% |
|
|---|---|---|---|
Usually |
5 | 18% |
|
Sometimes |
1 | 4% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Zolmitriptan
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
2 | 7% |
|
A little |
2 | 7% |
|
Not at all |
24 | 86% |
|
Cost
Paid out of pocket
Cost of Zolmitriptan
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 7% |
|
$25-49 |
3 | 20% |
|
< $25 |
10 | 67% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.